Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Weiss: Protection by Neutralizing Antibodies |
| Strategy: | Protein & peptide vaccines |
| Study Type: | Pre-Clinical Non-NHP |
| Species: | Guinea Pig |
| Stage: | Assays Completed |
| Study Start Date: | 2011-03-01 |
| Study Made Public: | 2012-02-14 |
Title
Comparison of a panel of gp140 using different production protocols
Description
CAVD 346 is an antigen comparison study in Guinea Pigs using env gp140 from elite neutralisers and structural modifications to increase immunogenicity.
Sign in to see full information about this study and to download study data.
Products
Env gp140 AN439856-impol Env gp140 AN439856-regen Env gp140 CA018-imcam Env gp140 CA018-impol Env gp140 CA018-regen Env gp140 CN54-impol Env gp140 HK20-imcam Env gp140 K530-regen Env gp140 R2-regen Env gp140 R2GCN-usuhs Env gp140 R2ditri-usuhs Env gp140 R2linkGCN-usuhs Env gp140 SF162-novar Env gp140 TV1-novar Env gp140 UG37-impol Env gp140 UG37-oxfor Env gp140 UG37-regenIntegrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.